Use of igf-1 in the preparation of medicaments for preventing and/or treating liver tumors
AssigneeDalian Medical University
InventorsAiguo WANG, Jingyu WANG, Xu ZHENG, Xiaoqin LUO, Huiling LI
Life of this patent
Estimating the term…
Loading patent…
AssigneeDalian Medical University
InventorsAiguo WANG, Jingyu WANG, Xu ZHENG, Xiaoqin LUO, Huiling LI
Estimating the term…
The present invention provides a use of IGF-1 in the preparation of medicaments for preventing and/or treating liver tumors, relating to the technological field of prevention and treatment of hepatocarcinoma. In embodiments of the present invention, experiments are carried out on mice, demonstrating that over-expression of IGF-1 in hepatocytes induces the apoptosis of cancerous cells indirectly, and inhibits the occurrence and development of liver tumors; high level of IGF-1 significantly promotes the function of thymus, delays the degeneration of thymus, and does not cause the dysfunction of thymus; high level of IGF-1 significantly promotes the function of spleen T lymphocyte; high level of IGF-1 significantly enhances the number and activity of tumor infiltrating T lymphocytes; long-term over-expression of IGF-1 does not significantly promote the incidence of tumors in all organs and tissues in mice, indicating the safety of high IGF-1 level in the body.
A method for preventing and/or treating liver tumors with IGF-1, comprising improving the level of IGF-1 in the body.
A medicament for preventing and/or treating liver tumors, comprising IGF-1 and excipients.
Dependencies are inferred from the claim text.